Combination therapies using HDAC inhibitors

Details for Australian Patent Application No. 2006210746 (hide)

Owner TopoTarget UK Limited

Inventors Sehested, Maxwell; Ritchie, James; Qian, Xiaozhang; Lichenstein, Henri; Petersen, Kamille Dumong; Jeffers, Mike

Agent FB Rice

Pub. Number AU-B-2006210746

PCT Pub. Number WO2006/082428

Priority 60/735,662 10.11.05 US; 60/649,991 03.02.05 US

Filing date 3 February 2006

Wipo publication date 10 August 2006

Acceptance publication date 26 April 2012

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 31/00 (2006.01)

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/282 (2006.01)

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/082428 Priority application(s): WO2006/082428

31 March 2011 Assignment before Grant

  CuraGen Corporation; TopoTarget UK Limited The application has been assigned to TopoTarget UK Limited

26 April 2012 Application Accepted

  Published as AU-B-2006210746

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210753-Method and use of interferon compositions for the treatment of avian influenza

2006210743-Battery management system